Spots Global Cancer Trial Database for et
Every month we try and update this database with for et cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance | NCT04285086 | Essential Throm... | Ropeginterferon... Anagrelide | 18 Years - | PharmaEssentia | |
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance | NCT04285086 | Essential Throm... | Ropeginterferon... Anagrelide | 18 Years - | PharmaEssentia | |
Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera | NCT01243073 | Essential Throm... Polycythemia Ve... | Imetelstat | 18 Years - | Geron Corporation | |
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders | NCT00433862 | Polycythemia Ve... Essential Throm... Idiopathic Myel... Neutrophils Chronic Myelopr... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders | NCT00433862 | Polycythemia Ve... Essential Throm... Idiopathic Myel... Neutrophils Chronic Myelopr... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm | NCT05025488 | Myelofibrosis Essential Throm... MPN | Peptide-based v... Poly ICLC | 18 Years - | Icahn School of Medicine at Mount Sinai |